Donna White

Donna White is an educator and advocate for evidence-based bioidentical hormone replacement therapy with a focus on healthy aging, regenerative medicine, and optimizing patient outcomes. She works with clinicians to integrate hormone optimization into comprehensive treatment strategies that support mitochondrial function, tissue repair, metabolic health, and long-term wellness.

Presentation

Why Your Ozone Patients Need Bioidenticals: The Evidence Is In, But Most Providers Are Still Behind

Ozone therapy optimizes the cellular terrain, but hormones are the upstream regulators of the same mitochondrial, antioxidant, and tissue repair pathways. This presentation explores why unrecognized hormone deficiencies can limit patient response to ozone therapy and explains how bioidentical hormone optimization complements regenerative medicine. Drawing on long-term clinical evidence, including the Women's Health Initiative follow-up, recent Menopause research involving more than 10 million women, and current JAMA safety data, Donna distinguishes bioidentical hormones from synthetic hormone therapies while addressing the misconceptions that continue to influence clinical practice. Attendees will gain a practical understanding of when hormone deficiencies may be limiting ozone outcomes and how appropriate hormone evaluation can improve patient recovery, energy, cognitive function, metabolic health, and overall treatment success.